Cardiovascular Systems Inc. (CSII)
-NasdaqGM 18.64 
0.45(2.36%) 3:13PM EDT - Nasdaq Real Time Price
| Prev Close: | 19.09 |
|---|
| Open: | 19.05 |
|---|
| Bid: | 18.56 x 300 |
|---|
| Ask: | 18.62 x 100 |
|---|
| 1y Target Est: | 21.90 |
|---|
| Beta: | 0.44 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 18.31 - 19.18 |
|---|
| 52wk Range: | 8.24 - 20.86 |
|---|
| Volume: | 109,222 |
|---|
| Avg Vol (3m): | 205,770 |
|---|
| Market Cap: | 448.12M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.07 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Cardiovascular Systems Releasing Late-Breaking ORBIT II Coronary Data at EuroPCR ConferenceBusiness Wire(Mon 10:00AM EDT)
- Tuesday 5/14 Insider Buying Report: CSII, POLat Forbes(Tue, May 14)
- Cardiovascular's CEO Discusses F3Q2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 1)
- Cardiovascular's CEO Discusses F3Q2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 1)
- Cardiovascular Systems, Inc. Earnings Call scheduled for 4:45 pm ET todayCCBN(Wed, May 1)
- Cardiovascular Systems Reports Fiscal 2013 Third-Quarter Financial ResultsBusiness Wire(Wed, May 1)
- Q3 2013 Cardiovascular Systems, Inc. Earnings Release - After Market CloseCCBN(Wed, May 1)
- Cardiovascular Systems Confirms U.S. Information Requestat Bloomberg(Tue, Apr 30)
- Tesla, Cardiovascular probed over stock trading plans: WSJReuters(Tue, Apr 30)
- Tesla, Cardiovascular probed over stock trading plans-WSJat Reuters(Tue, Apr 30)
- [$$] Directors Take Shelter in Trading Plansat The Wall Street Journal(Wed, Apr 24)
- Cardiovascular Systems to Webcast Fiscal 2013 Third-Quarter Earnings Conference Call Wednesday, May 1Business Wire(Wed, Apr 24)
- Why Cardiovascular Systems Will Keep Pulling Backat Motley Fool(Tue, Apr 23)
- 4 Stocks Rising on Unusual Volumeat TheStreet(Thu, Mar 21)
- Cardiovascular Systems 2M share Spot Secondary priced at $17.60at theflyonthewall.com(Wed, Mar 20)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 4.68 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | -1.13 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.30 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | -0.84 |
|---|
Business Summary
Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular disease.
View More